Trastuzumab Deruxtecan Is Active in Desmoplastic Small Round Cell Tumor We reviewed 168 patients with soft tissue LMS who received systemic therapy between 2009 and 2024 for metastatic LMS and also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results